Accumulating evidence indicates that PCa CSCs are characterized by the expression of specific cell surface markers, including CD133 and CD44, and are less differentiated than transient-amplifying (TA) or committed-basal (CB) cells10–12. This evidence concerns the gene CD44 and posterior cortical atrophy.